Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep 15:7:317.
doi: 10.3389/fphar.2016.00317. eCollection 2016.

Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs

Caroline Turcotte  1 , Marie-Renée Blanchet  1 , Michel Laviolette  1 , Nicolas Flamand  1
Affiliations
Review

Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs

Caroline Turcotte et al. Front Pharmacol. .

Abstract

Since the identification of cannabinoid receptors in the 1990s, a research field has been dedicated to exploring the role of the cannabinoid system in immunity and the inflammatory response in human tissues and animal models. Although the cannabinoid system is present and crucial in many human tissues, studying the impact of cannabinoids on the lungs is particularly relevant because of their contact with exogenous cannabinoids in the context of marijuana consumption. In the past two decades, the scientific community has gathered a large body of evidence supporting that the activation of the cannabinoid system alleviates pain and reduces inflammation. In the context of lung inflammation, exogenous and endogenous cannabinoids have shown therapeutic potential because of their inhibitory effects on immune cell recruitment and functions. On the other hand, cannabinoids were shown to be deleterious to lung function and to impact respiratory pathogen clearance. In this review, we present the existing data on the regulation of lung immunity and inflammation by phytocannabinoids, synthetic cannabinoids and endocannabinoids.

Keywords: cannabinoid; endocannabinoid; host defense; inflammation; lung.

PubMed Disclaimer

References

    1. Adhikary S., Kocieda V. P., Yen J. H., Tuma R. F., Ganea D. (2012). Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression. Blood 120 3741–3749. 10.1182/blood-2012-06-435362 - DOI - PMC - PubMed
    1. Alhouayek M., Masquelier J., Cani P. D., Lambert D. M., Muccioli G. G. (2013). Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6. Proc. Natl. Acad. Sci. U.S.A. 110 17558–17563. 10.1073/pnas.1314017110 - DOI - PMC - PubMed
    1. Baldwin G. C., Tashkin D. P., Buckley D. M., Park A. N., Dubinett S. M., Roth M. D. (1997). Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am. J. Respir. Crit. Care Med. 156 1606–1613. 10.1164/ajrccm.156.5.9704146 - DOI - PubMed
    1. Berdyshev E., Boichot E., Corbel M., Germain N., Lagente V. (1998). Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. Life Sci. 63 L125–L129. 10.1016/S0024-3205(98)00324-5 - DOI - PubMed
    1. Buchweitz J. P., Karmaus P. W., Harkema J. R., Williams K. J., Kaminski N. E. (2007). Modulation of airway responses to influenza A/PR/8/34 by Delta9-tetrahydrocannabinol in C57BL/6 mice. J. Pharmacol. Exp. Ther. 323 675–683. 10.1124/jpet.107.124719 - DOI - PubMed

LinkOut - more resources